• Home Study Details

  • Home / Learn / Home Study CE / Home Study Details


Updates in Diabetes Pharmacotherapy

Program Type

OnDemand

Credits

1 Contact Hour(s)

Release Date

Tuesday, March 1, 2016

Offline Date:

Thursday, March 1, 2018

ACPE Expiration Date

Saturday, September 1, 2018

Target Audience

Nurse, Pharmacist

Cost

$4.00

  • Overview

    Many new medications for the pharmacologic management of Type 2 Diabetes have been approved since 2013. In particular, the new inhaled insulin is a novel insulin delivery model for which pharmacists must become familiar to adequately instruct the public on appropriate and safe use and administration. It is essential for healthcare providers to be aware of the new medications to optimize patient care and deliver evidence-based pharmacologic management of Type 2 diabetes.

    Rating


    Handouts

    Slide Document:   SlideDocument_0798000015119H01.pdf

    Financial Support By

    Pharmaceutical Education Consultants, Inc.
  • Nurse

    List the names and mechanisms of action of the FDA approved SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP4 inhibitors approved for the treatment of Type 2 Diabetes since 2013
    Compare and contrast the new diabetes medications with existing diabetes treatment options.
    Provide appropriate recommendations for the newly approved diabetes medications in different patient cases.


    Pharmacist

    List the names and mechanisms of action of the FDA approved SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP4 inhibitors approved for the treatment of Type 2 Diabetes since 2013
    Compare and contrast the new diabetes medications with existing diabetes treatment options.
    Provide appropriate recommendations for the newly approved diabetes medications in different patient cases.

  • Activity Type

    Knowledge

    Universal Activity Number

    Nurse 0798-0000-15-119-H01-P

    Pharmacist 0798-0000-15-119-H01-P

    ACPE PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


HARDWARE REQUIREMENTS
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
 


SOFTWARE REQUIREMENTS
Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher


NETWORK REQUIREMENTS
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
 
 

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

 

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.